JLK Inc
KOSDAQ:322510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J & J Snack Foods Corp
NASDAQ:JJSF
|
US |
JLK Inc
Cost of Revenue
JLK Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
JLK Inc
KOSDAQ:322510
|
Cost of Revenue
-₩7.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Cost of Revenue
-₩36.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Cost of Revenue
-₩95.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Cost of Revenue
-₩685.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
e
|
ezCaretech Co Ltd
KOSDAQ:099750
|
Cost of Revenue
-₩53.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Cost of Revenue
-₩14.7B
|
CAGR 3-Years
-168%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JLK Inc
Glance View
JLK, Inc. develops AI based data-driven diagnostic system that detects brain disease. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2019-12-11. The firm develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
See Also
What is JLK Inc's Cost of Revenue?
Cost of Revenue
-7.8B
KRW
Based on the financial report for Sep 30, 2025, JLK Inc's Cost of Revenue amounts to -7.8B KRW.
What is JLK Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-18%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for JLK Inc have been -10% over the past three years , -18% over the past five years .
